InvestSMART

MGC Pharmaceuticals Ltd (ASX: MXC) - Announcements

Current share price for MXC : $0.420 0.01 (2.44%)+

ASX company news and announcements for MGC Pharmaceuticals Ltd (MXC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MGC Pharmaceuticals Ltd (MXC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MGC Pharmaceuticals Ltd (MXC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MGC Pharmaceuticals Ltd (MXC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Proposed issue of securities - MXC 21 Sep 2022 12:07PM $0.016 $0.420 risen by 2,525%
$18 Interim Results - CimetrA Dosing Finding Study 21 Sep 2022 9:26AM $0.015 $0.420 risen by 2,700%
$18 Website and Social Media Update 9 Sep 2022 1:37PM $0.016 $0.420 risen by 2,525%
$18 Letter to Shareholders-Dispatch of General Meeting Documents 5 Sep 2022 5:27PM $0.017 $0.420 risen by 2,445.45%
$18 Notice of General Meeting/Proxy Form 5 Sep 2022 5:14PM $0.017 $0.420 risen by 2,445.45%
$18 Preliminary Final Report 1 Sep 2022 9:11AM $0.017 $0.420 risen by 2,370.59%
$18 s708A(5)(e) Cleansing Notice 26 Aug 2022 5:31PM $0.018 $0.420 risen by 2,233.33%
$18 Application for quotation of securities - MXC 26 Aug 2022 5:31PM $0.018 $0.420 risen by 2,233.33%
$18 Notification regarding unquoted securities - MXC 26 Aug 2022 5:27PM $0.018 $0.420 risen by 2,233.33%
$18 s708A(12C)(e) Cleansing Notice 25 Aug 2022 9:20AM $0.018 $0.420 risen by 2,233.33%
$18 US$750,000 Convertible Note Facility Funding 25 Aug 2022 8:01AM $0.018 $0.420 risen by 2,233.33%
$18 Proposed issue of securities - MXC 25 Aug 2022 7:57AM $0.018 $0.420 risen by 2,233.33%
$18 AMC Holdings Inc places US$1 million ArtemiC order 17 Aug 2022 10:56AM $0.019 $0.420 risen by 2,110.53%
$18 Study Results - Effects of CannEpil on driving performance 15 Aug 2022 1:36PM $0.018 $0.420 risen by 2,233.33%
$18 Company Presentation (updated) 8 Aug 2022 7:05PM $0.018 $0.420 risen by 2,233.33%
$18 Company Presentation 8 Aug 2022 11:56AM $0.019 $0.420 risen by 2,110.53%
$18 s708A(5)(e) Cleansing Notice - Share Issue 5 Aug 2022 3:48PM $0.019 $0.420 risen by 2,110.53%
$18 Application for quotation of securities - MXC 5 Aug 2022 3:44PM $0.019 $0.420 risen by 2,110.53%
$18 Notification regarding unquoted securities - MXC 4 Aug 2022 2:54PM $0.019 $0.420 risen by 2,110.53%
$18 s708A(5)(e) Cleansing Note 3 Aug 2022 6:10PM $0.019 $0.420 risen by 2,110.53%
$18 Application for quotation of securities - MXC 3 Aug 2022 6:00PM $0.019 $0.420 risen by 2,110.53%
$18 Application for quotation of securities - MXC 3 Aug 2022 5:45PM $0.019 $0.420 risen by 2,110.53%
$18 Cleansing Notice - Convertible Securities 3 Aug 2022 2:28PM $0.019 $0.420 risen by 2,170.27%
$18 US$1.2M Tranche 1 Funding Recevied from Mercer 3 Aug 2022 2:17PM $0.019 $0.420 risen by 2,170.27%
$18 Proposed issue of securities - MXC 29 Jul 2022 10:55AM $0.020 $0.420 risen by 2,000%

176 - 200 of 818 results

Page 8 of 33

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.